Cloning and identification of promoter of suppressed-tumor gene NGX6

Progress in Biochemistry and Biophysics

Volumn 37, Issue 10, 2010, Pages 1082-1089

  Liu, Min Ji ^a   Wang, Xiao Yan ^a   Shen, Shou Rong ^a   Li, Nan ^a   Zhang, De Cai ^a   Peng, Ya ^a   Guo, Qin ^a   Li, Gui Yuan ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

NGX6 gene; Promoter; Sp1; Transcription regulate

Indexed keywords

EID: 79951897141     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2010.00102     Document Type: Article

References (20)

1. Yang J B, Tang X N, Deng L W, et al. Chin J Oncology, 1999, 21(6): 419-421
2. Yang J B, Bin L H, Li Z H, et al. Clin J Cancer, 2000, 19(1): 6-9
3. Ma J, Zhou J, Fan S Q, et al. Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells. Carcinogenesis, 2005, 26(2): 281-291 (Pubitemid 40246549)
4. Fan S Q, Zhang W L, Zhou M, et al. Prog Biochem Biophys, 2008, 35(9): 1014-1020
5. Li J, Huang Y C, Li W F, et al. The effect of NGX6 on cells from human nasopharyngeal carcinoma cell line HNE1. Chin J Biochem Mol Biol, 2002, 18(4): 398-403
6. Wang L, Zhang Q H, Ma J, et al. Prog Biochem Biophys, 2005, 32(7): 618-624
7. Li J, Huang Y C, Zhang Q H, et al. Life Sci Res, 2002, 6(4): 300-304
8. Wang L, Ma J, Li J, et al. NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. J Cell Biochem, 2005, 95(1): 64-73 (Pubitemid 41420216)
9. Wang X Y, Shen S R, Liu H Y, et al. World Chin J Digestology, 2004, 12(3): 572-579
10. Wang X Y, Shen S R, Liu F, et al. Prog Biochem Biophys, 2006, 33(1): 45-50
11. Liu F, Shen SR, LiH T, et al. J Central South University (Medical Sciences), 2007, 32(6): 985-991
12. Wang X Y, Shen S R, Liu F, et al. Prog Biochem Biophys, 2008, 35(5): 570-576
13. Cai L, Zhu J D. The tumor-selective over-expression of the human Hsp70 gene is attributed to the aberrant controls at both initiation and elongation levels of transcription. Cell Res, 2003, 13(2): 93-109
14. Cuenca J, Perez C A, Aguirre A J, et al. Genetic polymorphism at position-308 in the promoter region of the tumor necrosis factor (TNF): implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population. Biol Res, 2001, 34(3-4): 237-241 (Pubitemid 33064687)
15. Tayeb M T, Clark C, Sharp L, et al. CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia. Oncol Rep, 2002, 9(3): 653-655
16. Xiong W, Zeng Z Y, Li X L, et al. Chin J Biochem Mol Biol, 2002, 34(4): 512-515
17. Kadonaga J T, Carner K R, Masiarz F R, et al. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell, 1987, 51(6): 1079-1090
18. Chae Y M, Park K K, Magae J, et al. Sp1-decoy oligodeoxynucleotide Inhibits glucose-induced mesangial cell proliferation. Biochem Biophys Res Commun, 2004, 319(2): 550-555 (Pubitemid 38725981)
19. Safe S, Abdelrahim M. Sp1 transcription factor family and its role in cancer. Eur J Cancer, 2005, 41(16): 2438-2448 (Pubitemid 41540621)
20. Larsen F, Gundersen G, Lopez R, et al. CpG islands as gene markers in the human genome. Genomics, 1992, 13(4): 1095-1107